Lisinopril hydrochlorothiazide
Pro Research Analysisby 
Searched over 200M research papers for "lisinopril hydrochlorothiazide"
Comparative Analysis of Lisinopril and Hydrochlorothiazide in Hypertension Management
Introduction to Lisinopril and Hydrochlorothiazide
Lisinopril and hydrochlorothiazide are commonly used medications for managing hypertension. Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor, while hydrochlorothiazide is a thiazide diuretic. Both drugs have distinct mechanisms of action and are often used either as monotherapy or in combination to achieve optimal blood pressure control.
Efficacy in Obese Hypertensive Patients
A multicenter, double-blind trial compared the efficacy of lisinopril and hydrochlorothiazide in 232 obese hypertensive patients over 12 weeks. Both medications significantly lowered diastolic and systolic blood pressures compared to placebo. Lisinopril showed a slightly higher efficacy, with 60% of patients achieving a diastolic pressure below 90 mm Hg compared to 43% with hydrochlorothiazide . Additionally, lisinopril had a more favorable impact on plasma glucose levels and serum potassium, suggesting potential metabolic advantages .
Combination Therapy for Enhanced Blood Pressure Control
Several studies have demonstrated that combining lisinopril with hydrochlorothiazide enhances antihypertensive efficacy. A large multicenter study found that the combination of lisinopril and hydrochlorothiazide was more effective in reducing blood pressure than either drug alone, with no significant difference in efficacy between low and high doses of hydrochlorothiazide when combined with lisinopril . Another study confirmed that the combination therapy was superior to monotherapy in both short-term and long-term blood pressure control .
Hemodynamic and Metabolic Effects
The hemodynamic effects of lisinopril and hydrochlorothiazide were compared in a study involving essential hypertensive patients. Both drugs effectively reduced blood pressure, but lisinopril had a more favorable impact on blood rheology, potentially reducing the risk of atherosclerotic and thrombotic complications . Additionally, a 52-week study indicated that lisinopril was more effective than hydrochlorothiazide as a first-line treatment, and the combination of both drugs provided superior blood pressure control .
Pharmacokinetics and Bioequivalence
A pharmacokinetic study in healthy Chinese subjects demonstrated that lisinopril/hydrochlorothiazide tablets were bioequivalent to the reference product under both fasting and postprandial conditions. The study also highlighted a significant food effect on lisinopril, with a 20%-25% reduction in systemic exposure when taken postprandially .
Impact on Renal Function and Drug Levels
Research on rats with myocardial infarction showed that hydrochlorothiazide increased plasma levels of lisinopril by affecting renal clearance. This interaction suggests that combining hydrochlorothiazide with ACE inhibitors like lisinopril could enhance their efficacy by altering pharmacokinetics .
Comparative Studies with Other ACE Inhibitors
A multicenter study compared the combination of lisinopril and hydrochlorothiazide with captopril and hydrochlorothiazide. The lisinopril combination was found to be more effective in reducing diastolic blood pressure and had a similar safety profile to the captopril combination .
Conclusion
Lisinopril and hydrochlorothiazide are both effective in managing hypertension, with each having unique benefits. Lisinopril may offer metabolic advantages and better blood rheology, while hydrochlorothiazide can enhance the efficacy of ACE inhibitors through pharmacokinetic interactions. Combination therapy with lisinopril and hydrochlorothiazide provides superior blood pressure control compared to monotherapy, making it a valuable option for patients with hypertension.
Sources and full results
Most relevant research papers on this topic